Application of Transcriptional Benchmark Dose Values in Quantitative Cancer and Noncancer Risk Assessment
Authors:
- Russell S. ThomasRTRussell S. Thomas
- Harvey J. ClewellHCHarvey J. Clewell
- Melvin E. AndersenMAMelvin E. Andersen
- 22 November 2010
- journal article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 120 (1) , 194-205
Abstract
The traditional approach for estimating noncancer and cancer reference values in quantitative chemical risk assessment is time and resource intensive. The extent and nature of the studies required under the traditional approach has limited the number of chemicals with published risk assessments. In this study, female mice were exposed for 13 weeks to multiple concentrations of five chemicals that were positive in a 2-year cancer bioassay. Traditional histological and organ weight changes were evaluated, and gene expression microarray analysis was performed on the target tissues. The histological, organ weight changes, and the original tumor incidences in the original cancer bioassay were analyzed using standard benchmark dose (BMD) methods to identify noncancer and cancer points of departure, respectively. The dose-related changes in gene expression were also analyzed using a BMD approach and the responses grouped based on cellular biological processes. A comparison of the transcriptional BMD values with those for the traditional noncancer and cancer apical endpoints showed a high degree of correlation for specific cellular biological processes. For chemicals with human exposure data, the transcriptional BMD values were also used to calculate a margin of exposure. The margins of exposure ranged from 1900 to 54,000. Both the correlation between the BMD values for the transcriptional and apical endpoints and the margin of exposure analysis suggest that transcriptional BMD values may be used as potential points of departure for noncancer and cancer risk assessment.Keywords
This publication has 21 references indexed in Scilit:
- The Toxicity Data Landscape for Environmental ChemicalsEnvironmental Health Perspectives, 2009
- Genome-wide analysis of transcript isoform variation in humansNature Genetics, 2008
- Development and use of a single-animal whole-body system for inhalation exposureLab Animal, 2008
- Experimental Comparison and Evaluation of the Affymetrix Exon and U133Plus2 GeneChip ArraysPLOS ONE, 2007
- Using RNA sample titrations to assess microarray platform performance and normalization techniquesNature Biotechnology, 2006
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006
- Dose-dependent transitions in mechanisms of toxicity: case studiesToxicology and Applied Pharmacology, 2004
- Review Article: Compendium of Chemical Carcinogens by Target Organ: Results of Chronic Bioassays in Rats, Mice, Hamsters, Dogs, and MonkeysToxicologic Pathology, 2001
- On the Correlation Coefficient Between the TD50 and the MTDRisk Analysis, 1996
- An Overview of the Report: Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk AssessmentRisk Analysis, 1993